ANALYSIS OF A RANGE OF ABDOMINAL AND BOWEL SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA REPORTING INADEQUATE SYMPTOM CONTROL WITH LOPERAMIDE: RESULTS FROM ELUXADOLINE CLINICAL TRIALS

被引：0
|
作者：
Brenner, Darren M.
Sayuk, Gregory S.
Saeed, Mazen
Janiszewski, Peter
Liu, Louis W.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1327
引用
收藏
页码：S851 / S851
页数：1
相关论文
共 50 条
  • [31] Effects of a low FODMAP diet on the symptom management of patients with irritable bowel syndrome: a systematic umbrella review with the meta-analysis of clinical trials
    Khalighi Sikaroudi, Masoumeh
    Soltani, Sepideh
    Ghoreishy, Seyed Mojtaba
    Ebrahimi, Zohreh
    Shidfar, Farzad
    Dehnad, Afsaneh
    FOOD & FUNCTION, 2024, 15 (10) : 5195 - 5208
  • [32] PLECANATIDE FOR PATIENTS WITH CHRONIC IDIOPATHIC CONSTIPATION AND IRRITABLE BOWEL SYNDROME-CONSTIPATION: ANALYSIS OF ABDOMINAL PAIN FROM FOUR RANDOMIZED PHASE 3 CLINICAL TRIALS
    Bharucha, Adil E.
    Sayuk, Gregory S.
    Rosenberg, Jonathan
    Patel, Reema
    Dorn, Spencer D.
    GASTROENTEROLOGY, 2020, 158 (06) : S398 - S398
  • [33] Plecanatide for Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome-Constipation: Analysis of Abdominal Bloating From Four Randomized Phase 3 Clinical Trials
    Franklin, Howard
    Sayuk, Gregory S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S291 - S291
  • [34] MuDelta Treatment Improves Bowel Movement Frequency and Urgency Episodes in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: Results of a Phase 2 Clinical Trial
    Covington, P. S.
    Andrae, D.
    Dove, S.
    Randall, C. W.
    Randall, C. W.
    Davenport, J.
    McIntyre, G.
    Almenoff, J.
    GASTROENTEROLOGY, 2012, 142 (05) : S161 - S161
  • [35] Effect of Eluxadoline on Health-Related Quality of Life in Adults With Irritable Bowel Syndrome With Diarrhea: Results From Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials
    Andrae, David
    Buono, Jessica L.
    Covington, Paul S.
    GASTROENTEROLOGY, 2015, 148 (04) : S494 - S494
  • [36] Plecanatide Improves Symptoms of Irritable Bowel Syndrome with Constipation: Results of an Integrated Efficacy and Safety Analysis of Two Phase 3 Trials
    Brenner, Darren M.
    Dorn, Spencer
    Fogel, Ronald P.
    Christie, Jennifer
    Laitman, Adam P.
    Rosenberg, Jonathan
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 3769 - 3777
  • [37] Analysis of Potential Predictors of Symptom Recurrence in Patients Treated with Rifaximin for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
    Lembo, Anthony J.
    Rao, Satish
    Wolf, Ray
    Pimentel, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S253
  • [38] RACE-RELATED COMPARISONS OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION SYMPTOMS, TREATMENT RESPONSE, AND QUALITY OF LIFE: RESULTS OF A POOLED ANALYSIS OF LINACLOTIDE CLINICAL TRIALS
    Nguyen, Linda Anh B.
    Chang, Lin
    Wu, James
    Kosch, Katherine
    Halberg, Daniel
    Almansa, Cristina
    GASTROENTEROLOGY, 2022, 162 (07) : S934 - S935
  • [39] Efficacy and Safety of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation: Pooled Analysis of 2 Randomized Clinical Trials
    Krause, Richard
    Christie, Jennifer
    Kirshoff, Robert
    Nguyen, Anhthu
    Griffin, Patrick
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S254 - S254
  • [40] Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms-Constipation Using Phase IIb Clinical Trial Data
    Coon, Cheryl D.
    Hanlon, Jennifer
    Abel, Jessica L.
    Lundy, J. Jason
    Carson, Robyn T.
    Reasner, David S.
    VALUE IN HEALTH, 2020, 23 (03) : 362 - 369
12345